CAD 0.01
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -989 Thousand CAD | 90.44% |
2022 | -10.34 Million CAD | 64.72% |
2021 | -29.31 Million CAD | -95.11% |
2020 | -15.02 Million CAD | 18.54% |
2019 | -18.44 Million CAD | -4853.84% |
2018 | -372.34 Thousand CAD | -302.86% |
2017 | -92.42 Thousand CAD | -107.96% |
2016 | 1.16 Million CAD | 439.32% |
2015 | -342.33 Thousand CAD | -801.52% |
2014 | -37.97 Thousand CAD | -39.95% |
2013 | -27.13 Thousand CAD | -109.56% |
2012 | 283.71 Thousand CAD | 708.26% |
2011 | -46.64 Thousand CAD | 91.73% |
2010 | -563.89 Thousand CAD | 22.16% |
2009 | -724.41 Thousand CAD | -91.48% |
2008 | -378.31 Thousand CAD | 37.19% |
2007 | -602.31 Thousand CAD | -374.84% |
2006 | -126.84 Thousand CAD | 45.57% |
2005 | -233.06 Thousand CAD | -448092.31% |
2004 | -52.00 CAD | 0.0% |
2003 | - CAD | 100.0% |
2002 | -34.00 CAD | 91.69% |
2001 | -409.00 CAD | -219.53% |
2000 | -128.00 CAD | 0.0% |
1999 | - CAD | 0.0% |
1998 | - CAD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 412 Thousand CAD | 141.66% |
2024 Q2 | 646 Thousand CAD | 189.56% |
2023 Q2 | -4.46 Million CAD | 55.18% |
2023 Q4 | -989 Thousand CAD | 50.92% |
2023 Q1 | -9.96 Million CAD | 3.69% |
2023 Q3 | -2.01 Million CAD | 54.87% |
2023 FY | -989 Thousand CAD | 90.44% |
2022 Q4 | -10.34 Million CAD | 42.47% |
2022 Q2 | -21.46 Million CAD | 16.56% |
2022 FY | -10.34 Million CAD | 64.72% |
2022 Q1 | -25.72 Million CAD | 12.24% |
2022 Q3 | -17.97 Million CAD | 16.25% |
2021 Q3 | -35.22 Million CAD | 12.12% |
2021 FY | -29.31 Million CAD | -95.11% |
2021 Q1 | -45.64 Million CAD | -203.79% |
2021 Q2 | -40.07 Million CAD | 12.2% |
2021 Q4 | -29.31 Million CAD | 16.77% |
2020 Q2 | -11.74 Million CAD | 21.04% |
2020 Q4 | -15.02 Million CAD | -76.57% |
2020 Q1 | -14.87 Million CAD | 19.36% |
2020 Q3 | -8.5 Million CAD | 27.54% |
2020 FY | -15.02 Million CAD | 18.54% |
2019 Q1 | 334.42 Thousand CAD | 1273.34% |
2019 Q3 | -22.94 Million CAD | 17.91% |
2019 Q2 | -27.95 Million CAD | -8458.2% |
2019 Q4 | -18.44 Million CAD | 19.61% |
2019 FY | -18.44 Million CAD | -4853.84% |
2018 FY | -372.34 Thousand CAD | -302.86% |
2018 Q1 | -137.96 Thousand CAD | 37.24% |
2018 Q3 | -805.00 CAD | 99.13% |
2018 Q4 | -28.5 Thousand CAD | -3440.62% |
2018 Q2 | -92.42 Thousand CAD | 33.01% |
2017 Q4 | -219.82 Thousand CAD | -118.68% |
2017 Q3 | 1.17 Million CAD | 1.29% |
2017 Q2 | 1.16 Million CAD | 2863.74% |
2017 Q1 | -42.03 Thousand CAD | 40.86% |
2017 FY | -92.42 Thousand CAD | -107.96% |
2016 Q1 | -207.41 Thousand CAD | -1269.89% |
2016 FY | 1.16 Million CAD | 439.32% |
2016 Q3 | -87.77 Thousand CAD | 74.36% |
2016 Q4 | -71.06 Thousand CAD | 19.03% |
2016 Q2 | -342.33 Thousand CAD | -65.05% |
2015 Q3 | -65.12 Thousand CAD | -71.5% |
2015 Q1 | -7732.00 CAD | 85.06% |
2015 Q2 | -37.97 Thousand CAD | -391.11% |
2015 FY | -342.33 Thousand CAD | -801.52% |
2015 Q4 | -15.14 Thousand CAD | 76.75% |
2014 Q1 | -38.29 Thousand CAD | 44.85% |
2014 Q3 | -6335.00 CAD | 76.65% |
2014 Q4 | -51.74 Thousand CAD | -716.73% |
2014 Q2 | -27.13 Thousand CAD | 29.15% |
2014 FY | -37.97 Thousand CAD | -39.95% |
2013 Q2 | 283.71 Thousand CAD | 4.87% |
2013 FY | -27.13 Thousand CAD | -109.56% |
2013 Q1 | 270.54 Thousand CAD | 48.49% |
2013 Q4 | -69.44 Thousand CAD | -614.18% |
2013 Q3 | -9724.00 CAD | -103.43% |
2012 Q4 | 182.19 Thousand CAD | 1096.05% |
2012 FY | 283.71 Thousand CAD | 708.26% |
2012 Q1 | 82.39 Thousand CAD | 171.22% |
2012 Q2 | 73.24 Thousand CAD | -11.1% |
2012 Q3 | -18.29 Thousand CAD | -124.98% |
2011 FY | -46.64 Thousand CAD | 91.73% |
2011 Q4 | -115.69 Thousand CAD | 69.03% |
2011 Q2 | -563.89 Thousand CAD | -26.5% |
2011 Q1 | -445.77 Thousand CAD | 30.48% |
2011 Q3 | -373.6 Thousand CAD | 33.75% |
2010 FY | -563.89 Thousand CAD | 22.16% |
2010 Q1 | -882.67 Thousand CAD | 33.89% |
2010 Q2 | -724.41 Thousand CAD | 17.93% |
2010 Q3 | -884.64 Thousand CAD | -22.12% |
2010 Q4 | -641.23 Thousand CAD | 27.51% |
2009 Q3 | -1.48 Million CAD | -293.0% |
2009 FY | -724.41 Thousand CAD | -91.48% |
2009 Q1 | -667.88 Thousand CAD | 40.38% |
2009 Q4 | -1.33 Million CAD | 10.19% |
2009 Q2 | -378.31 Thousand CAD | 43.36% |
2008 Q1 | -970.41 Thousand CAD | 19.04% |
2008 Q2 | -602.31 Thousand CAD | 37.93% |
2008 Q3 | -1.07 Million CAD | -78.15% |
2008 Q4 | -1.12 Million CAD | -4.4% |
2008 FY | -378.31 Thousand CAD | 37.19% |
2007 FY | -602.31 Thousand CAD | -374.84% |
2007 Q4 | -1.19 Million CAD | -195.05% |
2007 Q3 | -406.23 Thousand CAD | -475.93% |
2007 Q2 | -70.53 Thousand CAD | 56.49% |
2007 Q1 | -162.1 Thousand CAD | 28.7% |
2006 Q2 | -233.06 Thousand CAD | 4.71% |
2006 Q3 | -335.61 Thousand CAD | -44.0% |
2006 Q4 | -227.37 Thousand CAD | 32.25% |
2006 FY | -126.84 Thousand CAD | 45.57% |
2006 Q1 | -244.58 Thousand CAD | -63.02% |
2005 Q1 | 141.2 Thousand CAD | -58.14% |
2005 Q2 | -52.00 CAD | -100.04% |
2005 Q4 | -150.03 Thousand CAD | -441188.24% |
2005 Q3 | -34.00 CAD | 34.62% |
2005 FY | -233.06 Thousand CAD | -448092.31% |
2004 FY | -52.00 CAD | 0.0% |
2004 Q1 | 2.00 CAD | 0.0% |
2004 Q2 | - CAD | -100.0% |
2004 Q3 | -28.00 CAD | 0.0% |
2004 Q4 | 337.31 Thousand CAD | 1204792.86% |
2003 Q3 | -16.00 CAD | 52.94% |
2003 Q4 | 2.00 CAD | 112.5% |
2003 Q1 | -731.00 CAD | -6.1% |
2003 FY | - CAD | 100.0% |
2003 Q2 | -34.00 CAD | 95.35% |
2002 Q1 | -2889.00 CAD | 0.0% |
2002 FY | -34.00 CAD | 91.69% |
2002 Q4 | -689.00 CAD | -68.46% |
2002 Q3 | -409.00 CAD | 0.0% |
2002 Q2 | -409.00 CAD | 85.84% |
2001 Q2 | -128.00 CAD | 0.0% |
2001 FY | -409.00 CAD | -219.53% |
2001 Q1 | - CAD | 0.0% |
2001 Q3 | -3395.00 CAD | -2552.34% |
2001 Q4 | - CAD | 100.0% |
2000 Q4 | - CAD | 0.0% |
2000 FY | -128.00 CAD | 0.0% |
2000 Q3 | - CAD | 0.0% |
1999 FY | - CAD | 0.0% |
1998 FY | - CAD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Aurora Cannabis Inc. | -8.64 Million CAD | 88.564% |
Avicanna Inc. | 1.32 Million CAD | 174.574% |
Avant Brands Inc. | 17.93 Million CAD | 105.516% |
Cardiol Therapeutics Inc. | -34.77 Million CAD | 97.156% |
Crescita Therapeutics Inc. | -8.13 Million CAD | 87.837% |
Knight Therapeutics Inc. | 10.33 Million CAD | 109.574% |
MediPharm Labs Corp. | -15.68 Million CAD | 93.695% |
OrganiGram Holdings Inc. | -33.7 Million CAD | 97.066% |
Canopy Growth Corporation | 512.87 Million CAD | 100.193% |
Auxly Cannabis Group Inc. | 142.88 Million CAD | 100.692% |